Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,147 | 359,215 | 47,862 | 108,743 | 46,464 |
| Receivables | 65,310 | 65,574 | 70,020 | 86,177 | 72,984 |
| Other current assets | 88,542 | 75,240 | 89,049 | 75,730 | 393,522 |
| TOTAL | $214,662 | $515,775 | $221,811 | $280,288 | $520,819 |
| Non-Current Assets | |||||
| PPE Net | 1,781,321 | 2,018,142 | 1,978,826 | 2,035,342 | 1,820,735 |
| Investments And Advances | 550,573 | 455,168 | 463,251 | 479,276 | 495,488 |
| Intangibles | 0 | 0 | 0 | 19,514 | 0 |
| Other Non-Current Assets | 66,076 | 80,109 | 82,045 | 64,058 | 64,723 |
| TOTAL | $2,397,970 | $2,553,419 | $2,524,122 | $2,598,190 | $2,380,946 |
| Total Assets | $2,612,632 | $3,069,194 | $2,745,933 | $2,878,478 | $2,901,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 183,448 | 502,013 | 251,250 | 216,519 | 218,094 |
| Accounts payable and accrued liabilities | 104,175 | 93,502 | 7,913 | 13,524 | 29,671 |
| Accrued Expenses | 29,598 | 26,423 | 24,365 | 26,180 | 25,206 |
| Other current liabilities | N/A | N/A | 6,517 | N/A | 8,752 |
| TOTAL | $320,250 | $628,789 | $296,847 | $262,701 | $288,128 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,562,283 | 1,706,170 | 1,728,310 | 1,888,634 | 1,880,122 |
| Deferred Revenues | 3,029 | 6,851 | 6,802 | 6,478 | 6,405 |
| Other Non-Current Liabilities | 3,417 | 5,579 | 4,148 | 5,124 | 4,899 |
| TOTAL | $1,590,142 | $1,741,375 | $1,761,619 | $1,925,630 | $1,920,397 |
| Total Liabilities | $1,910,392 | $2,370,164 | $2,058,466 | $2,188,331 | $2,208,525 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,285 | 17,742 | 17,553 | 17,506 | 17,487 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 503,321 | 495,733 | 486,924 | 489,757 | 493,294 |
| Other shareholders' equity | 98,122 | 96,305 | 97,199 | 97,098 | 97,235 |
| TOTAL | $702,240 | $699,030 | $687,467 | $690,147 | $693,240 |
| Total Liabilities And Equity | $2,612,632 | $3,069,194 | $2,745,933 | $2,878,478 | $2,901,765 |